X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2023-12-27 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $7.17 | +321,616 | 7,099,182 | +5% | +$2,305,132 | |||||
M | 2023-12-21 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $6.45 | +504,652 | 6,777,566 | +8% | +$3,256,191 | |||||
M | 2023-12-15 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $5.63 | +1,233,931 | 6,272,914 | +24% | +$6,941,716 | |||||
M | 2023-11-14 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $2.94 | -32,846 | 92,392 | -26% | -$96,689 | |||||
M | 2023-11-14 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $2.94 | -8,853 | 86,257 | -9% | -$26,061 | |||||
M | 2023-11-14 | VRCA | Kohler Terry | CFO | S - Sale | $2.94 | -28,084 | 34,416 | -45% | -$82,671 | |||||
M | 2023-11-14 | VRCA | White Ted | Pres, CEO | S - Sale | $2.94 | -33,699 | 170,090 | -17% | -$99,200 | |||||
M | 2023-11-14 | VRCA | Hayes Christopher G. | GC | S - Sale | $2.94 | -33,699 | 123,226 | -21% | -$99,200 | |||||
2023-07-24 | VRCA | Hayes Christopher G. | GC | S - Sale | $4.83 | -33,789 | 81,925 | -29% | -$163,201 | ||||||
2023-07-24 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $4.83 | -28,699 | 70,110 | -29% | -$138,616 | ||||||
2023-07-24 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $4.83 | -38,262 | 62,738 | -38% | -$184,805 | ||||||
2023-07-24 | VRCA | White Ted | Pres, CEO | S - Sale | $4.83 | -50,677 | 128,789 | -28% | -$244,770 | ||||||
2023-07-24 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $5.02 | +200,000 | 15,589,481 | +1% | +$1,004,000 | ||||||
A | 2022-07-05 | VRCA | White Ted | Pres, CEO | P - Purchase | $2.10 | +7,500 | 29,466 | +34% | +$15,750 | |||||
2022-07-11 | VRCA | Hayes Christopher G. | GC | P - Purchase | $3.40 | +7,500 | 15,714 | +91% | +$25,500 | ||||||
2022-07-05 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $2.10 | +1,428,571 | 5,038,983 | +40% | +$2,999,999 | ||||||
2022-07-05 | VRCA | Hayes Christopher G. | GC | P - Purchase | $2.10 | +5,714 | 8,214 | +229% | +$11,999 | ||||||
2022-07-05 | VRCA | White Ted | Pres, CEO | P - Purchase | $2.10 | +23,809 | 29,466 | +421% | +$49,999 | ||||||
2022-07-05 | VRCA | Goldenberg Gary | Chief Medical Officer | P - Purchase | $2.10 | +23,809 | 23,809 | New | +$49,999 | ||||||
2022-07-05 | VRCA | Stalfort John A III | Dir | P - Purchase | $2.10 | +238,095 | 700,205 | +52% | +$500,000 | ||||||
2022-07-05 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $2.10 | +4,761,904 | 15,389,481 | +45% | +$9,999,998 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |